|
Howard CHANG, MD, PhD
Professor, Stanford University, USA
Howard Hughes Medical Institute
|
|
|
Muthiah MANOHARAN, PhD
Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals, USA
Board Director, Oligonucleotide Therapeutics Society
|
|
|
|
|
|
|
Stanley CROOKE, MD, PhD
Founder, CEO and Chairman of the Board
Ionis Pharmaceuticals, USA
|
|
|
Craig MELLO, PhD
Professor, University of Massachusetts
Howard Hughes Medical Institute, USA
Nobel Prize in Physiology or Medicine (2006)
|
|
|
|
|
|
|
Mark EDBROOKE, PhD
Director, AstraZeneca, UK
|
|
|
Mikiko SIOMI, PhD
Professor, the University of Tokyo, Japan
|
|
|
|
|
|
|
Jan GORODKIN, PhD
Professor, University of Copenhagen, Denmark
|
|
|
William SKARNES, PhD
Senior Group Leader
Wellcome Trust Sanger Institute, UK
|
|
|
|
|
|
|
Chuan HE, PhD
Professor, University of Chicago, USA
Howard Hughes Medical Institute
|
|
|
Erik SONTHEIMER, PhD
Professor, University of Massachusetts
Medical School, USA
|
|
|
|
|
|
|
Robert HOLT, PhD
Professor, University of British Columbia, Canada
|
|
|
Jian-Sheng SUN, PhD, HDR
Professor, Muséum National d’Histoire Naturelle
MNHN-CNRS-INSERM, France
|
|
|
|
|
|
|
Jin-Soo KIM, PhD
Professor, Seoul National University
Director, Institute for Basic Science, South Korea
|
|
|
Elizabeth TRAN, PhD
Associate Professor
Purdue University, USA
|
|
|
|
|
|
|
Troels KOCH, PhD
VP and Head of Research, RNA Therapeutics
Roche, Denmark / Switzerland
|
|
|
Ada YONATH, PhD
Professor, Weizmann Institute of Science, Israel
Nobel Prize in Chemistry 2009
|
|
|
|
|
|
|
Ekkehard LEBERER, PhD
Professor, Senior Director, Sanofi, Germany
|
|
|
Yi-Tao YU, PhD
Professor, University of Rochester Medical Center,School of Medicine and Dentistry, USA
|
|
|
|
|
|
|
Judy LIEBERMAN, MD, PhD
Professor, Program Chair,
Harvard MedicalSchool,USA
|
|
|
|
|
|
|
|
|